Skip to main content
Equibles

Qube Research & Technologies Ltd

Position in GILD — Gilead Sciences, Inc.

CIK 1729829 LONDON, X0
Back to GILD Full portfolio

Position in GILD

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$389,906,212
+$373,035,195 QoQ
Shares Held
3,086,166
+2449.5% QoQ
Ownership
0.249%
of shares outstanding
% of Portfolio
0.45%
of 13F equity value
Holder Rank
#51
of 2,275 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in GILD Over Time

Shares Held

Position Value (USD)

Derivatives in GILD

reported options exposure · as of Jun 30, 2026
CallValue
$6,594,948
CallShares
52,200
PutValue
$7,946,786
PutShares
62,900

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Qube Research & Technologies Ltd holds $1,498,530,307 across 11 Drug Manufacturers - General names. GILD ranks #2 (26.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 LLY
ELI LILLY & Co
 346,498 $415,600,130
2 GILD
Gilead Sciences, Inc.
This page 		3,086,166 $389,906,212
3 JNJ
Johnson & Johnson
 752,337 $191,071,027
4 BMY
Bristol Myers Squibb Co
 3,093,958 $178,273,859
5 MRK
Merck & Co., Inc.
 1,044,210 $134,180,985
6 AZN
Astrazeneca PLC
 375,473 $71,197,190
7 GSK
GSK plc
 1,078,767 $56,548,966
8 SNY
Sanofi
 634,794 $27,080,312

All Filings in GILD

Export CSV
47 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $7,946,786 62,900
2026-06-30 $389,906,212 3,086,166
2026-06-30 $6,594,948 52,200
2026-03-31 $9,128,735 65,500
2026-03-31 $6,299,524 45,200
2026-03-31 $16,871,017 121,052
2025-12-31 $6,566,590 53,500
2025-12-31 $312,623,444 2,547,038
2025-12-31 $8,763,636 71,400
2025-09-30 $535,969,161 4,828,551
2025-09-30 $3,729,600 33,600
2025-09-30 $6,560,100 59,100
2025-06-30 $11,452,871 103,300
2025-06-30 $30,200,988 272,400
2025-06-30 $527,583,210 4,758,575
2025-03-31 $9,703,530 86,600
2025-03-31 $147,838,770 1,319,400
2025-03-31 $264,133,896 2,357,286
2024-12-31 $3,371,505 36,500
2024-12-31 $1,339,365 14,500
2024-09-30 $2,833,792 33,800
2024-09-30 $2,121,152 25,300
2024-06-30 $3,759,828 54,800
2024-06-30 $103,574,547 1,509,613
2024-06-30 $31,526,295 459,500
2024-03-31 $8,599,550 117,400
2024-03-31 $162,076,978 2,212,655
2023-12-31 $1,004,524 12,400
2023-12-31 $19,239,875 237,500
2023-12-31 $57,034,928 704,048
2023-09-30 $13,226,910 176,500
2023-09-30 $3,154,974 42,100
2023-09-30 $86,205,280 1,150,324
2023-06-30 $10,674,195 138,500
2023-06-30 $23,121 300
2023-06-30 $55,624,578 721,741
2023-03-31 $17,966,323 216,540
2022-09-30 $59,910,490 971,154
2022-06-30 $41,525,997 671,833
2022-03-31 $34,045,172 572,669
2021-12-31 $59,013,196 812,742
2021-09-30 $3,587,984 51,367
2021-06-30 $3,787,850 55,008
2021-03-31 $6,062,875 93,809
2020-12-31 $1,501,185 25,767
2020-09-30 $26,693,857 422,438
2020-03-31 $3,908,976 52,287

Report a Problem

Category
Description
Email (optional, for follow-up)